Correction to: Journal of Neurology (2022) 269:3064–3074 https://doi.org/10.1007/s00415-021-10893-z

The original version of this article unfortunately contained a mistake. In Table 4, the second paragraph regarding SLEDAI, NP items, is wrong and should be excluded from the table. It was based on results from a preliminary regression analysis that were included in the table. In an old dataset four patients were wrongly marked to have neuropsychiatric manifestations with consequences for scoring in the SLEDAI. Later in the process this was double-checked against the original database, where none of the patients were scored with NP-items in the SLEDAI. Correct data have been used everywhere else in the manuscript, but we are sorry to say that it was overlooked in the table and in a reference to the table in the text.

In section “Multivariable regression analyses with both laboratory and clinical variables” paragraph which previously read:

Based on the results of initial regression analyses, we included creatinine, Q-albumin, and aPL in multivariable regression analyses. In the above-mentioned models, the SLEDAI NP items, motor function, and a history of seizures were found to exert an effect on plasma NfL concentrations (Table 4). However, SDI scores, lacunar infarcts, cognitive (all domains), or specifically memory or language dysfunction in multivariable regression analyses did not exert an effect on the plasma NfL concentrations (data not shown).


should have read


Based on the results of initial regression analyses, we included creatinine, Q-albumin, and aPL in multivariable regression analyses. In the above-mentioned models, motor function, and a history of seizures were found to exert an effect on plasma NfL concentrations (Table 4). However, SDI scores, lacunar infarcts, cognitive (all domains), or specifically memory or language dysfunction in multivariable regression analyses did not exert an effect on the plasma NfL concentrations (data not shown).

The corrected Table 4 is given below.

Table 4 Associations between NfL plasma concentrations and laboratory and clinical variables in 67 patients with SLE